- Home
- XCUR vs KNRX Comparison
XCUR vs KNRX Comparison
Compare XCUR & KNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XCUR | KNRX |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 14.1M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | XCUR | KNRX |
|---|---|---|
| Price | $1.89 | $0.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 43.1K | ★ 104.4K |
| Earning Date | 03-25-2026 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.43 | $0.34 |
| 52 Week High | $9.48 | $3.45 |
Technical Indicators
Market Signals| Indicator | XCUR | KNRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.75 | 32.60 |
| Support Level | $1.71 | $0.34 |
| Resistance Level | $3.40 | $0.50 |
| Average True Range (ATR) | 0.28 | 0.05 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 46.74 | 22.80 |
Price Performance
Historical ComparisonAbout XCUR Exicure Inc.
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
About KNRX KNOREX LTD. Class A Ordinary Shares
Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. The company's product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications.